SourceBio International (LON: SBI) has warned that it will be hit by the updated Covid-19-related travel requirements that mean that inbound fully vaccinated people will not need PCR tests on days two and eight. The effect on the diagnostics and storage company’s results is uncertain and the share price slumped 29.5p to 133p, but it is building up a cash pile and the operations are modestly rated.
Business will not disappear. Volumes had been growing and they will fall back. The average numb...
You are unauthorized to view this page.
